Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05069428
PHASE4
Delirium Reduction With Ramelteon
Sponsor: Centennial Medical Center
View on ClinicalTrials.gov
Summary
The overall purpose of this study is to identify a medication that might treat and/or prevent delirium in intensive care unit (ICU). Currently, there is no proven medical therapy for prevention or treatment of delirium. Ramelteon is a medication approved for insomnia. We hypothesize that ramelteon may help regulate the day/night cycle and decrease ICU delirium.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
506
Start Date
2023-03-26
Completion Date
2025-12
Last Updated
2024-08-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
Ramelteon 8mg
administered crushed, orally at 20:30
Locations (1)
Centennial Medical Center
Nashville, Tennessee, United States